Swiss National Bank’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.16M Hold
61,100
﹤0.01% 1816
2025
Q4
$2.48M Buy
61,100
+1,100
+2% +$47.9K ﹤0.01% 1765
2025
Q3
$2.82M Buy
60,000
+900
+2% +$46.7K ﹤0.01% 1672
2025
Q2
$3.08M Sell
59,100
-800
-1% -$43.9K ﹤0.01% 1556
2025
Q1
$3.62M Sell
59,900
-700
-1% -$45.1K ﹤0.01% 1437
2024
Q4
$4.15M Buy
60,600
+500
+0.8% +$34.8K ﹤0.01% 1445
2024
Q3
$4.32M Sell
60,100
-500
-0.8% -$35.3K ﹤0.01% 1412
2024
Q2
$4.2M Hold
60,600
﹤0.01% 1379
2024
Q1
$4.85M Hold
60,600
﹤0.01% 1320
2023
Q4
$6.64M Sell
60,600
-6,700
-10% -$693K ﹤0.01% 1106
2023
Q3
$6.79M Buy
67,300
+700
+1% +$80.4K 0.01% 1100
2023
Q2
$9.05M Buy
66,600
+800
+1% +$97.7K 0.01% 964
2023
Q1
$6.83M Sell
65,800
-7,700
-10% -$745K ﹤0.01% 1077
2022
Q4
$6.52M Buy
73,500
+3,500
+5% +$290K ﹤0.01% 1156
2022
Q3
$5.61M Buy
70,000
+800
+1% +$75.5K ﹤0.01% 1207
2022
Q2
$6.63M Hold
69,200
﹤0.01% 1154
2022
Q1
$10.3M Buy
69,200
+5,000
+8% +$698K 0.01% 1012
2021
Q4
$9.1M Sell
64,200
-100
-0.2% -$14.2K 0.01% 1062
2021
Q3
$8.41M Buy
64,300
+500
+0.8% +$65.4K 0.01% 1092
2021
Q2
$8.77M Sell
63,800
-1,600
-2% -$219K 0.01% 1093
2021
Q1
$8.54M Buy
65,400
+700
+1% +$84.2K 0.01% 1092
2020
Q4
$7.25M Hold
64,700
0.01% 1127
2020
Q3
$5.09M Buy
64,700
+1,100
+2% +$89.7K ﹤0.01% 1168
2020
Q2
$4.58M Buy
63,600
+8,600
+16% +$598K ﹤0.01% 1198
2020
Q1
$3.15M Buy
55,000
+800
+1% +$73.8K ﹤0.01% 1180
2019
Q4
$6.06M Buy
54,200
+1,100
+2% +$117K 0.01% 1030
2019
Q3
$5.11M Buy
53,100
+800
+2% +$75.1K 0.01% 1087
2019
Q2
$4.47M Buy
52,300
+6,100
+13% +$501K ﹤0.01% 1195
2019
Q1
$3.84M Buy
46,200
+1,500
+3% +$109K ﹤0.01% 1249
2018
Q4
$2.87M Buy
44,700
+900
+2% +$61.6K ﹤0.01% 1330
2018
Q3
$3.47M Hold
43,800
﹤0.01% 1361
2018
Q2
$3.21M Hold
43,800
﹤0.01% 1396
2018
Q1
$2.77M Buy
43,800
+2,100
+5% +$125K ﹤0.01% 1428
2017
Q4
$2.13M Hold
41,700
﹤0.01% 1613
2017
Q3
$2.19M Hold
41,700
﹤0.01% 1560
2017
Q2
$2.12M Buy
41,700
+2,400
+6% +$119K ﹤0.01% 1560
2017
Q1
$1.75M Hold
39,300
﹤0.01% 1649
2016
Q4
$1.74M Hold
39,300
﹤0.01% 1653
2016
Q3
$1.57M Sell
39,300
-2,600
-6% -$110K ﹤0.01% 1667
2016
Q2
$2M Sell
41,900
-1,100
-3% -$46.6K ﹤0.01% 1506
2016
Q1
$1.75M Buy
43,000
+7,600
+21% +$298K ﹤0.01% 1527
2015
Q4
$1.56M Hold
35,400
﹤0.01% 1509
2015
Q3
$1.69M Buy
35,400
+4,200
+13% +$231K ﹤0.01% 1418
2015
Q2
$1.82M Sell
31,200
-1,800
-5% -$97.1K ﹤0.01% 1373
2015
Q1
$1.67M Buy
33,000
+500
+2% +$24.5K ﹤0.01% 1414
2014
Q4
$1.46M Buy
32,500
+700
+2% +$29.3K 0.01% 1496
2014
Q3
$1.17M Sell
31,800
-900
-3% -$35.7K ﹤0.01% 1571
2014
Q2
$1.44M Hold
32,700
0.01% 1493
2014
Q1
$1.42M Buy
32,700
+6,800
+26% +$303K 0.01% 1465
2013
Q4
$1.1M Hold
25,900
﹤0.01% 1440
2013
Q3
$880K Sell
25,900
-1,500
-5% -$48.9K ﹤0.01% 1545
2013
Q2
$856K Buy
+27,400
New +$889K ﹤0.01% 1532

Other funds holding CNMD

Swiss National Bank's CNMD Position: Q1 2026 in Review

Swiss National Bank held its CONMED (CNMD) position steady in Q1 2026 at 61,100 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #1816.

Swiss National Bank first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.3M in Q1 2022. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Swiss National Bank held 61,100 shares of CONMED worth $2.16M as of Q1 2026.
  • Swiss National Bank left its CONMED share count unchanged in Q1 2026.
  • CONMED made up ﹤0.01% of Swiss National Bank's portfolio in Q1 2026, its #1816 holding.
  • Swiss National Bank first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
  • Swiss National Bank's CONMED position peaked at $10.3M in Q1 2022.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.